INFLUENZA A
Clinical trials for INFLUENZA A explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA A trials appear
Sign up with your email to follow new studies for INFLUENZA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AstraZeneca launches human tests for bird flu vaccines
⭐️ VACCINE ⭐️ OngoingThis study tests two experimental vaccines, AZD4117 and AZD5315, designed to protect against certain strains of avian influenza (bird flu), specifically H5N1 and H7N9. Around 405 healthy adults will receive either a vaccine or a placebo to see if the vaccines are safe and trigger…
Matched conditions: INFLUENZA A
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:00 UTC
-
New flu pill for kids shows promise in early trial
Symptom relief OngoingThis study tests a new medicine called ZSP1273 in children aged 2 to 11 who have influenza A. The goal is to see if it can shorten flu symptoms and is safe. About 119 children in China will take either ZSP1273 or the standard flu drug oseltamivir.
Matched conditions: INFLUENZA A
Phase: PHASE3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New flu pill shows promise for teens in Late-Stage trial
Symptom relief OngoingThis phase 3 trial tests whether the experimental drug ZSP1273 can shorten flu symptoms in teenagers aged 12-17 with uncomplicated influenza A. About 157 participants in China will receive either the drug or a placebo. The main goal is to see how quickly symptoms like cough, feve…
Matched conditions: INFLUENZA A
Phase: PHASE3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC